“Telmisartan Attenuates Experimental Liver Fibrosis Through Suppression Of Hepatic Stellate Cell Activation And Tgf-Β Smad Signaling”. The Review of Diabetic Studies , June 2026, pp. 62-76, https://doi.org/10.70082/y1zx3j95.